Maegan Weltzin

Research DescriptionMaegan Weltzin

The research goals of the Weltzin lab are to understand the role of neuronal nicotinic
acetylcholine receptors (nAChRs) in neurological disorders and infectious disease. nAChRs are
ligand gated ion channels that are highly expressed in the central nervous system and
periphery. They are involved in many diseases such as Alzheimer鈥檚 disease, nicotine addiction,
epilepsy and certain viral infections. The Weltzin lab has several research objectives:


1) Investigate endogenous protein modulation of nAChR function and expression to understand
how these interactions are involved in healthy and disease states.
2) Characterize the cellular mechanism of neuronal nAChR interactions with specific viral
glycoproteins.
3) Develop cell penetrating peptides from viral glycoproteins that are highly selective for nAChR
subtypes.


The Weltzin lab performs electrophysiology, cell culture, confocal microscopy, cell viability,
among other biochemical assays. By addressing basic and translational research questions, the
Weltzin team aims to develop novel therapeutic approaches to diseases that are associated
with altered cholinergic tone.


The Weltzin team is always interested in collaborating with fellow researchers, and accepting
new undergraduate and graduate student members. Please contact Dr. Maegan Weltzin
(mmweltzin@alaska.edu) to discuss research opportunities.

Maegan Weltzin CV

Selected Publications

  • BCV O鈥橞rien, L Weber, K Hueffer, MM Weltzin. (2023) SARS-CoV-2 spike ectodomain targets
    伪7 nicotinic acetylcholine receptors. Journal of Biological Chemistry, 104707. DOI:
  • M Lian, K Hueffer, M Weltzin. (2022) 鈥淚nteractions between the rabies virus and nicotinic
    acetylcholine receptors: A potential role in rabies virus induced behavior modifications.鈥 Heliyon,
    e10434. DOI:
  • MM Weltzin, AA George, RJ Lukas, P Whiteaker. (2021) Sleep-related hypermotor epilepsy
    associated mutations uncover important kinetic roles of 伪4尾2-nicotinic acetylcholine receptor
    intracellular structures. Plos one 16 (3), e0247825. DOI:
  • MM Weltzin, AA George, RJ Lukas, P Whiteaker. (2019) 鈥淒istinctive single-channel properties
    of 伪4尾2-nicotinic acetylcholine receptor isoforms.鈥 PloS one 14 (3), e0213143. DOI:
  • MM Weltzin, JM Lindstrom, RJ Lukas, P Whiteake. (2016) Distinctive effects of nicotinic
    receptor intracellular-loop mutations associated with nocturnal frontal lobe epilepsy.
    Neuropharmacology 102, 158-173. DOI:
  • MM Weltzin and MK Schulte. (2015) Desformylflustrabromine modulates 伪4尾2 neuronal
    nicotinic acetylcholine receptor high-and low-sensitivity isoforms at allosteric clefts containing the 尾2 subunit. Journal of Pharmacology and Experimental Therapeutics 354 (2), 184-194. DOI:
  • S Luo, D Zhangsun, CI Schroeder, X Zhu, Y Hu, Y Wu, MM Weltzin, S Eberhard, Q Kaas, DJ
    Craik, JM McIntosh, P Whiteaker. (2014) A novel 伪4/7-conotoxin LvIA from Conus lividus that
    selectively blocks 伪3尾2 vs. 伪6/伪3尾2尾3 nicotinic acetylcholine receptors. The FASEB Journal 28
    (4), 1842. DOI: 10.1096/fj.13-244103
  • MM Weltzin, MK Schulte. (2010) Pharmacological characterization of the allosteric modulator
    desformylflustrabromine and its interaction with 伪4尾2 neuronal nicotinic acetylcholine receptor
    orthosteric ligands. Journal of Pharmacology and Experimental Therapeutics 334 (3), 917-926.
    DOI:  https://doi.org/10.1124/jpet.110.167684

Degree(s)

  • Postdoctoral Fellow, 03/2012 - 07/2016 Barrow Neurological Institute at St. Joseph鈥檚 Hospital, Phoenix, AZ.
  • Ph.D., 2011, Biochemistry and Molecular Biology (emphasis in Neuroscience), University of 草榴社区 Fairbanks, Fairbanks, AK.
  • B.S., 2006, Chemistry with emphasis in Biochemistry, University of 草榴社区 Fairbanks, Fairbanks, AK.

Contact

Phone: 907-474-6527
Fax: 907-474-5640
Email: mmweltzin@alaska.edu
Address:
Maegan Weltzin
Department of Chemistry & Biochemistry
University of 草榴社区 Fairbanks
Fairbanks, AK 99775-6160